References

  1. Rossing P. Prediction, progression and prevention of diabetic nephropathy The Minkowski Lecture 2005. Diabetologia. 2006;49:11-9. This article on PubMed

  2. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164-76. This article on PubMed

  3. International Diabetes Federation. Diabetes Atlas. 4th ed. Brussels: IDF; 2009

  4. Parving HH, Hommel E. High blood pressure is a major factor in progression of diabetic nephropathy. J Diabet Complications. 1988;2:92-5. This article on PubMed

  5. Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003;163:1555-65. This article on PubMed

  6. Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829-40. This article on PubMed

  7. Felicio JS, de Souza AC, Kohlmann N, Kohlmann O, Jr, Ribeiro AB, Zanella MT. Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes. Cardiovasc Diabetol. 2010;9:36. This article on PubMed

  8. Knudsen ST, Laugesen E, Hansen KW, Bek T, Mogensen CE, Poulsen PL. Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients. Diabetologia. 2009;52:698-704. This article on PubMed

  9. Zinman B, Hoogwerf BJ, Duran Garcia S, Milton DR, Giaconia JM, Kim DD, et al. The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial. Ann Intern Med. 2007;146:477-85. This article on PubMed

  10. Cohen JD, Perlstein WM, Braver TS, Nystrom LE, Noll DC, Jonides J, et al. Temporal dynamics of brain activation during a working memory task [see comments]. Nature. 1997;386:604-8. This article on PubMed

  11. Farmer CK, Goldsmith DJ, Quin JD, Dallyn P, Cox J, Kingswood JC, et al. Progression of diabetic nephropathy--is diurnal blood pressure rhythm as important as absolute blood pressure level?. Nephrol Dial Transplant. 1998;13:635-9. This article on PubMed

  12. Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med. 1991;10:1025-35. This article on PubMed

  13. Kengne AP, Czernichow S, Huxley R, Grobbee D, Woodward M, Neal B, et al. Blood pressure variables and cardiovascular risk: new findings from ADVANCE. Hypertension. 2009;54:399-404. This article on PubMed

  14. Pencina MJ, DŽAgostino RB, Vasan RS. Comments on ŽIntegrated discrimination and net reclassification improvements - Practical adviceŽ. Stat Med. 2008;27:207-212

  15. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus Randomized controlled trial comparing blood and urine testing. Diabetes Care. 1990;13:1044-50. This article on PubMed

  16. Ishikawa T, Hashimoto J, Morito RH, Hanazawa T, Aikawa T, Hara A, et al. Association of microalbuminuria with brachial-ankle pulse wave velocity: the Ohasama study. Am J Hypertens. 2008;21:413-8. This article on PubMed

  17. Palmas W, Pickering T, Teresi J, Schwartz JE, Eguchi K, Field L, et al. Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J Clin Hypertens (Greenwich). 2008;10:12-20. This article on PubMed

  18. Palmas W, Moran A, Pickering T, Eimicke JP, Teresi J, Schwartz JE, et al. Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension. 2006;48:301-8. This article on PubMed

  19. Tanaka M, Babazono T, Takeda M, Iwamoto Y. Pulse pressure and chronic kidney disease in patients with type 2 diabetes. Hypertens Res. 2006;29:345-52. This article on PubMed

  20. Knudsen ST, Andersen NH, Mogensen CE. Ambulatory pulse pressure and progression of albuminuria in type 2 diabetes: evidence provided, new questions emerge. Hypertension. 2006;48:207-8. This article on PubMed

  21. Arulkumaran N, Diwakar R, Tahir Z, Mohamed M, Kaski JC, Banerjee D. Pulse pressure and progression of chronic kidney disease. J Nephrol. 2010;23:189-93. This article on PubMed

  22. Gosse P, Coulon P, Papaioannou G, Litalien J, Lemetayer P. Long-term decline in renal function is linked to initial pulse pressure in the essential hypertensive. J Hypertens. 2009;27:1303-8. This article on PubMed

  23. Farasat SM, Valdes C, Shetty V, Muller DC, Egan JM, Metter EJ, et al. Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure?. Hypertension. 2010;55:415-21. This article on PubMed